Cite

Characteristics of patients in group 1 and 2

Clinical data Group 1 (n = 115) Group 2 (n = 22)
n % n %
Type 1 diabetes 13 11.3 2 9.1
Type 2 diabetes 91 79.1 20 90.9
Other specific types of diabetes 9 7.8 0 -
No data on the type of diabetes 2 1.7 0 -
Male 87 75.7 16 72.7
Female 28 24.3 6 27.3
Neuropathic foot ulcers 52 45.2 14 63.6
Neuro-ischemic foot ulcers 50 43.5 7 31.8
Ischemic foot ulcers 11 9.6 1 4.5
Indeterminate type 2 1.7 0 -
Obesity 46 40.0 14 63.6
Overweight 16 13.9 4 18.9
Normal weight 25 21.7 3 13.6
Lack of body weight data 28 24.4 1 4.5
Age in years ± SD 59.7±10.02 58.5±9.68
Duration of diabetes in years ± SD 17.03±10.36 16.9±12.09

Results of microbiological cultures in terms of the number of microorganisms isolated in the culture in group 1 and 2

Results of cultures (n = 200) Group 1 (n = 137) Group 2 (n = 63)
no growth 16 (11.7%) 1 (1.6%)
one microorganism 49 (35.8%) 21 (33.3%)
two microorganisms 33 (24.0%) 17 (27.0%)
three microorganisms 13 (9.5%) 13 (20.6%)
more than three microorganisms 26 (19.0%) 11 (17.5%)

Percentage of HbA1c values of patients in the group 1 and 2

Hba1c % <6.0 6.0–6.9 7.0–7.9 8.0–8.9 9.0–9.9 10.0–10.9 11.0–11.9 >12
Group 1 7.8% 34.3% 23.5% 20.6% 7.8% 2.0% 2.9% 1.0%
Group 2 2.1% 25.0% 29.2% 20.8% 20.8% 0.0% 0.0% 2.1%

Quantitative and percentage distribution of microbial species isolated from wounds in patients with DFU in both study groups

Microorganism Number/percent
Aerobic and facultatively anaerobic Gram-negative rods: in total 187/48,44%

Enterobacterales: 145/37.56%
1. Enterobacteriaceae 41/10.62%
E. coli * including 1 strain ESBL(+) 15/3,89%
E. cloacae * including 2 strains ESBL(+) 9
Enterobacter spp. 2
E. amnigenus 1
K. oxytoca 5
K. pneumoniae * including 2 strains ESBL(+) 3
C. freundii 5
C. braakii 1
2. Yersiniaceae 49/12.69%
S. marcescens 48/12,43%
Serratia spp. 1
3. Hafniaceae 1/0.26%
H. alvei 1
4. Morganellaceae 54/13.99%
P. mirabilis 27
P. vulgaris 9
P. penneri 1
M. morganii 14
P. stuartii 2
P. rettgeri 1
Pseudomonas aeruginosa 27/6.99%
* including 3 strains resistant to carbapenems, 3 strains resistant to ≥2 antibiotics
Acinetobacter spp. 9/2.33 %
A. baumannii * including 2 strains resistant to carbapenems,3 strains resistant to ≥2 antibiotics 7
A. haemolyticus 1
A. pittii 1
Other Gram-negative rods: A. hydrophila, A. faecalis, P. multocida, B. cepacia 6/1.55%

Fungi: in total 3/0.78%

Candida spp. 3/0.78%
C. albicans 2
C. parapsilosis 1

Facultatively anaerobic Gram-positive bacteria: in total 113/29,27%

Staphyloccous aureus 46/11.92 %
* including 14 (3.63%) MRSA strains Coagulase negative staphylococci
S. epidermidis 11/2.85 %
S. simulans 7
S. haemolyticus 2
S. cohnii 1
Streptococcus spp. 1
S. agalactiae 34/8.81 %
Streptococcus spp. 9
β-haemolytic streptococci group C, 7
G and F 5
S. dysgalactiae
S. oralis 4
S. intermedius 4
S. mitis, S. anginosus, S. sanguinis 2
Enterococcus spp. 3
E. faecalis 12/3.11%
E. faecium 11/2,85%
Other Gram-positive bacteria: 1
Corynebacterium spp., Leuconostoc spp., D. hominis, H. kunzi, M. luteus 10/2.59%

Anaerobes: in total 83/21.5%

Peptostreptococcus spp. 21/5.44 %
F. magna 11/2.85 %
B. fragilis 5
B. thetaiotaomicron 4
B. ovatus 1
Prevotella spp. 7
Peptoniphilus spp. 7
Anaerococcus spp. 7
Peptococcus spp. 6
Fusobacterium spp. 5
Veillonella spp. 4
Actinomyces spp. 2
Porphyromonas spp. 1

Percentage distribution of HbA1c values in patients with selected microorganisms isolated in the culture

Microorganism Hba1c mean value HBA1c ± SD HbA1c <8 HbA1c 8-12,3 Lack of HbA1c measurements
Pseudomonas aeruginosa 7.2 0.9 71.4% 14.3% 14.3%
Peptostreptococcus spp. 7.4 1.1 66.7% 23.8% 9.5%
Serratia marcescens 7.5 1.1 62.0% 32.0% 6.0%
Proteus mirabilis 7.7 1.0 42.9% 39.3% 17.8%
Staphylococcus aureus MSSA* 7.9 1.4 59.1% 38.6% 2.3%
Escherichia coli 8.1 1.5 43.75% 50.0% 6.25%
Morganella morganii 8.8 1.1 18.75% 56.25% 25.0%

Median and interquartile range and minimum and maximum values of HBA1c concentration in groups of patients infected with different strains of bacteria

Bacteria N Mean ± SD Median Min Max CV* [%] SEM**
Serratia marcescens 47 7.5 ± 1.1 7.4 5.2 9.7 14.9 0.2
MSSA 43 7.9 ± 1.4 7.7 5.7 12.3 18.1 0.2
Pseudomonas aeruginosa 24 7.2 ± 0.9 7.3 6.1 9.0 12.4 0.2
Proteus mirabilis 23 7.6 ± 1 7.4 5.9 9.1 13.7 0.2
Peptostreptococcus spp. 19 7.4 ± 1.1 7.4 6.0 9.6 14.9 0.3
Escherichia coli 15 8.1 ± 1.5 8.2 5.9 11.1 18.5 0.4
Morganella morganii 12 8.8 ± 1.1 8.7 7.2 11.1 12.5 0.3

Microorganisms isolated from clinical samples obtained from patients with DFU in various geographical zones

Publication I II III IV V VI VII VIII IX X XI
Year of publication 2006 2007 2009 2011 2011 2014 2014 2015 2016 2018 2020
Number of patients 80 433 379 434 440 196 102 41 447 261 137
Microorganism in
Staphylococcus aureus MSSA* 13.7 14.3 17.3 13.8 3.0 21.0 13.6 30.0 9.6 26.9 8.3
Staphylococcus aureus MRSA** 4.4 11.3 N/A 8.0 N/A 1.0 N/A 1.8 3.6
Streptococus spp. N/A 15.5 12.6 3.0 4.0 4.7 3.0 9.0 7.2 1.7 8.8
Enterococcus spp. 11.5 13.6 7.7 9.5 6.0 3.4 16.0 N/A 4.4 12.7 3.1
coagulase-negative Staphylococci 6.6 15.2 14.9 5.0 0.5 N/A 11.5 N/A 1.3 N/A 2.8
Escherichia coli 12.0 1.7 N/A 16.1 6.0 28.6 7.0 4.5 15.0 12 3.9
Proteus mirabilis 12.6 2.1 N/A 8.8 6.0 4.2 7.6 11.0 9.6 3.1 7.0
Pseudomonas aeruginosa 9.8 3.5 6.9 16.9 17.0 N/A 7.5 4.5 12.4 20.9 7.0
Acinetobacter spp. 9.3 1.1 N/A 3.7 N/A 4.2 2.0 N/A 2.8 1 2.3
Klebsiella spp. 6.6 2.2 N/A 6.7 5.0 14.3 3.5 N/A 3.4 9.5 2.1
Serratia marcescens N/A 1.2 N/A N/A 2.0 N/A 2.0 N/A 1.6 0.3 12.4
Morganella morganii N/A N/A N/A N/A 3.0 N/A 1.5 N/A 4.9 N/A 3.6
Peptostreptococcus spp. 1.6 N/A N/A N/A N/A N/A 1.5 N/A N/A N/A 5.4
Bacteroides fragilis 1.6 4.1 N/A N/A N/A N/A 1.0 N/A N/A N/A 1.3
eISSN:
1732-2693
Language:
English